Research Perspectives: Advanced Ovarian Cancer and PARP Inhibitors: Clinical Insights and Impact on New Data

To participate in this activity, please:

In this CME activity, Susana M. Campos, MD, MS, MPH, reviews some of the recent clinical developments in the treatment of patients with advanced ovarian cancer with PARP inhibitors. We welcome you to learn more about the updated data from key clinical studies of PARP inhibitor maintenance therapy in advanced ovarian cancer, and the implications of the results on the current and emerging concepts in ovarian cancer clinical practice.

Course Credit:

0.50 AMA PRA Category 1 CreditsTM

Dates:

Opens: 2021-09-29
Closes: 2022-09-29

Target Audience:

This activity is intended for medical oncologists, gynecologic oncologists, and other healthcare professionals involved in the treatment of patients with advanced ovarian cancer.

This educational activity is supported by an educational grant from GlaxoSmithKline.

    Presenting Faculty

  • Susana Campos, MD, MS, MPH

    Assistant Professor, Medicine
    Harvard Medical School
    Boston, Massachusetts

Learning Objectives

  • Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors in ovarian cancer
  • Incorporate evidence-based research into clinical practice to improve patient outcomes

Faculty Disclosures

Susana Campos, MD, MS, MPH

Advisory Board: AstraZeneca, Eisai, GlaxoSmithKline


Accreditation and Certification

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Content Planners

Krithika Subramanian, PhD (Medical Writer)
No significant relationships to disclose.

Annenberg Center for Health Sciences

Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.